Personalis, Inc.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

PSNL

organization

SIC: 8071Active: 2012–2026

Also known as: PERSONALIS, INC., Personalis, Inc.

Contract Awards

$246.1M

55 awards

SEC Insider

$148.6M

433 transactions

Summary

Personalis, Inc. (PSNL) is an organization. Its political footprint includes $246.1 million in government contracts. Their largest government contract source is Department of Veterans Affairs at $246.0 million. Political activity spans from 2012 to 2026.

Cross-Source Financial Activity

These are different money flows and are not added together: contributions and lobbying expenses flow out, while contract awards flow to the organization.

Contract awards $246.1M

Insider Trading

↑ $56.8M buys↓ $64.0M sales

38 insiders

Political Money Flow

How Money Flows

Government agencies → Personalis, Inc. (contracts) → political recipients & lobbying. Hover for details.

Contracts by Agency

2 agencies

#	Agency	Total Awarded	Awards
1	Department of Veterans Affairs	$246.0M	54
2	Department of Health and Human Services	$46K	1

Individual Awards

54 awards (top by amount)

Date	Agency	Description	Amount	NAICS
2019-09-25	Department of Veterans Affairs	GENOMIC SEQUENCING	$38.1M	TESTING LABORATORIES
2017-09-28	Department of Veterans Affairs	GENOMIC SEQUENCING IGF::OT::IGF	$36.6M	TESTING LABORATORIES
2018-09-14	Department of Veterans Affairs	GENOMIC SEQUENCING	$36.5M	TESTING LABORATORIES
2020-09-16	Department of Veterans Affairs	GENOMIC SEQUENCING	$30.9M	TESTING LABORATORIES
2016-09-25	Department of Veterans Affairs	GENOMIC SEQUENCING IGF::OT::IGF	$20.1M	RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY
2025-08-19	Department of Veterans Affairs	WHOLE GENOME SEQUENCING	$13.5M	RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
2023-12-15	Department of Veterans Affairs	WHOLE GENOME SEQUENCING	$10.0M	RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
2021-09-17	Department of Veterans Affairs	GENOMIC SEQUENCING	$9.7M	TESTING LABORATORIES
2013-09-27	Department of Veterans Affairs	GENOME SEQUENCING IGF::OT::IGF	$9.0M	RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY
2025-11-05	Department of Veterans Affairs	WHOLE GENOME SEQUENCING	$7.5M	RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
2024-11-20	Department of Veterans Affairs	WHOLE GENOME SEQUENCING	$7.5M	RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
2012-09-29	Department of Veterans Affairs	GENOMICS SEQUENCING.	$4.2M	RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY
2020-05-11	Department of Veterans Affairs	ONCOLOGY TESTING SERVICES	$1.1M	MEDICAL LABORATORIES
2025-03-18	Department of Veterans Affairs	WHOLE GENOME SEQUENCING	$334K	RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
2014-09-30	Department of Veterans Affairs	IGF::OT::IGF THE CONTRACTOR SHALL PROVIDE ENHANCED ANALYSIS OF CLINICAL AND SPECIMEN-DERIVED DATA ON ALL PATIENTS SEEN AT VA NETWORK HOSPITALS WHO HAVE A CANCER DIAGNOSIS. THE CONTRACTOR SHALL FURNISH A ROBUST, SCALABLE, DYNAMIC, SECURE, INNOVATIVE SOLUTIONS OF ANALYZING SAMPLES OBTAINED DURING REGULAR CLINICAL CARE SUCH AS TISSUES FROM BIOPSY - USING NEW GENOMIC ASSAY TECHNOLOGY. THE CLIA VENDOR SHALL PROVIDE EMERGING TECHNOLOGIES TO IMPROVE ONCOLOGY CARE FOR ALL PATIENTS WITHIN THE VA HEALTHCARE SYSTEM. THE CONTRACTOR SHALL PROVIDE TARGETED SEQUENCING OF DNA FRAGMENTS KNOWN TO HARBOR MUTATIONS IN CANCER SPECIMENS (COMMONLY REFERRED TO AS A MUTATION PANEL). THE NUMBER OF DNA SEGMENTS SEQUENCED VARIES BY THE LABORATORY AND ASSAY PERFORMED. MUTATIONS IN THE DNA CAN EITHER BE INFERRED AGAINST A LABORATORY `REFERENCE SEQUENCE OR CAN BE DETERMINED BY SEQUENCING OF PATIENT GERM-LINE DNA OBTAINED FROM ADJACENT NORMAL TISSUE OR PERIPHERAL BLOOD. THE CONTRACTORS SHALL PROVIDE SEQUENCING OF THE WHOLE EXOME OF CANCER SPECIMENS, WITH MUTATIONS IDENTIFIED BY COMPARISON AGAINST A LABORATORY `REFERENCE SEQUENCE OR GERM-LINE DNA AS DESCRIBED ABOVE. THE CONTRACOTR SHALL PROVIDE SEQUENCING OF THE CANCER SPECIMEN RNA OR `TRANSCRIPTOME . THIS STRATEGY CAN BE COMBINED WITH EITHER TARGETED OR WHOLE EXOME DNA SEQUENCING. PRODUCTS OF THE TESTING RETURNED TO THE VA INCLUDE ALL SEQUENCE DATA INCLUDING RAW TEST DATA (FAST-Q, BAM, READ QUALITY FILES AND VARIANT CALL FILES) AND A REPORT OF IMPORTANT MUTATIONS AND THEIR SIGNIFICANCE TO BE RETURNED TO THE MEDICAL RECORD. MUTATIONS FOUND IN THE TUMOR SAMPLE WILL BE ANNOTATED SO THAT CLINICIANS CAN GAIN AN UNDERSTANDING OF THEIR MEANING. THE LABORATORY SHALL SPECIFY HOW THIS ANNOTATION WILL BE PERFORMED AND IN PARTICULAR, WHAT KNOWLEDGE BASE WILL BE USED TO GENERATE THE ANNOTATIONS. THE CONTRACTOR SHALL MAINTAINS AN UP-TO-DATE KNOWLEDGE BASE AND MUST BE ABLE TO UPDATE ANNOTATIONS OF A PATIENT REPORT UPON REQUEST. THE CONTRACTOR SHALL AT ALL TIMES MANINTAIN A SECURE ENVIRONMENT AND PRACTICE COVERING ALL PROTECTED HEALTH INFORMATION (PHI).	$300K	RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY
2016-09-28	Department of Veterans Affairs	IGF::OT::IGF THE CONTRACTOR SHALL PROVIDE ENHANCED ANALYSIS OF CLINICAL AND SPECIMEN DERIVED DATA ON ALL PATIENTS SEEN AT VA NETWORK HOSPITALS WHO HAVE A CANCER DIAGNOSIS. THIS MODIFICATION INCORPORATES ACE CANCERPLUS TEST TEST NUMBER 13-0414 TUMOR ONLY, WITH CLINICAL REPORT ONLY; THE TEST IS A 181 CANCER GENE TEST, AND THE SAME AS ACE CANCERPLUS LESS THE RESEARCH DATA COMPONENT IN SOW TASK 8, PARAGRAPH 2.	$291K	RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY
2013-09-27	Department of Veterans Affairs	IGF::OT::IGF GENOMIC SEQUENCING	$275K	RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY
2015-09-30	Department of Veterans Affairs	GENOMIC SEQUENCING IGF::OT::IGF	$248K	RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY
2025-08-28	Department of Veterans Affairs	WHOLE GENOME SEQUENCING	$231K	RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
2017-08-01	Department of Veterans Affairs	IGF::OT::IGF THE CONTRACTOR SHALL PROVIDE ENHANCED ANALYSIS OF CLINICAL AND SPECIMEN DERIVED DATA ON ALL PATIENTS SEEN AT VA NETWORK HOSPITALS WHO HAVE A CANCER DIAGNOSIS. THIS MODIFICATION INCORPORATES ACE CANCERPLUS TEST TEST NUMBER 13-0414 TUMOR ONLY, WITH CLINICAL REPORT ONLY; THE TEST IS A 181 CANCER GENE TEST, AND THE SAME AS ACE CANCERPLUS LESS THE RESEARCH DATA COMPONENT IN SOW TASK 8, PARAGRAPH 2.	$225K	RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY
2017-09-27	Department of Veterans Affairs	IGF::OT::IGF GENOMIC ANALYSIS OF CANCER TUMORS	$169K	RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY
2017-04-18	Department of Veterans Affairs	IGF::OT::IGF P00002 MODIFY AND SUPPLEMENT DISTRIBUTION OF CLINICAL REPORTS AND CLARIFY FILE FORMAT TYPES. P00002. THE CONTRACTOR SHALL PROVIDE ENHANCED ANALYSIS OF CLINICAL AND SPECIMEN DERIVED DATA ON ALL PATIENTS SEEN AT VA NETWORK HOSPITALS WHO HAVE A CANCER DIAGNOSIS. THIS MODIFICATION INCORPORATES ACE CANCERPLUS TEST TEST NUMBER 13-0414 TUMOR ONLY, WITH CLINICAL REPORT ONLY; THE TEST IS A 181 CANCER GENE TEST, AND THE SAME AS ACE CANCERPLUS LESS THE RESEARCH DATA COMPONENT IN SOW TASK 8, PARAGRAPH 2.	$150K	RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY
2018-09-19	Department of Veterans Affairs	IGF::OT::IGF ONCOLOGY TESTING SERVICES	$110K	MEDICAL LABORATORIES
2022-09-26	Department of Veterans Affairs	AUGMENTED EXOME SEQUENCING SERVICES	$100K	MEDICAL LABORATORIES
2016-06-10	Department of Veterans Affairs	IGF::OT::IGF THE CONTRACTOR SHALL PROVIDE ENHANCED ANALYSIS OF CLINICAL AND SPECIMEN DERIVED DATA ON ALL PATIENTS SEEN AT VA NETWORK HOSPITALS WHO HAVE A CANCER DIAGNOSIS. THIS MODIFICATION INCORPORATES ACE CANCERPLUS TEST TEST NUMBER 13-0414 TUMOR ONLY, WITH CLINICAL REPORT ONLY; THE TEST IS A 181 CANCER GENE TEST, AND THE SAME AS ACE CANCERPLUS LESS THE RESEARCH DATA COMPONENT IN SOW TASK 8, PARAGRAPH 2.	$99K	RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY

1–25 of 54

1 / 3

SEC filings: SEC EDGAR

Activity data: USAspending.gov · SEC EDGAR

Personalis, Inc. — Contributions, Lobbying & Contracts | Poliscope